223 related articles for article (PubMed ID: 22520466)
21. Immunobiotic
Sato N; Garcia-Castillo V; Yuzawa M; Islam MA; Albarracin L; Tomokiyo M; Ikeda-Ohtsubo W; Garcia-Cancino A; Takahashi H; Villena J; Kitazawa H
Front Immunol; 2020; 11():2174. PubMed ID: 33042131
[TBL] [Abstract][Full Text] [Related]
22. Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with synbiotic Syngut on experimental colitis under stress conditions.
Konturek PC; Konturek K; Brzozowski T; Wojcik D; Magierowski M; Targosz A; Krzysiek-Maczka G; Sliwowski Z; Strzalka M; Magierowska K; Szczyrk U; Kwiecien S; Ptak-Belowska A; Neurath M; Dieterich W; Wirtz S; Zopf Y
J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991312
[TBL] [Abstract][Full Text] [Related]
23. Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells.
Matsumoto S; Hara T; Hori T; Mitsuyama K; Nagaoka M; Tomiyasu N; Suzuki A; Sata M
Clin Exp Immunol; 2005 Jun; 140(3):417-26. PubMed ID: 15932502
[TBL] [Abstract][Full Text] [Related]
24. Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis.
Moeinian M; Ghasemi-Niri SF; Mozaffari S; Abdolghaffari AH; Baeeri M; Navaea-Nigjeh M; Abdollahi M
World J Gastroenterol; 2014 Aug; 20(31):10876-85. PubMed ID: 25152589
[TBL] [Abstract][Full Text] [Related]
25. On the benefit of whey-cultured Lactobacillus casei in murine colitis.
Ghasemi-Niri SF; Abdolghaffari AH; Fallah-Benakohal S; Hosseinpour-Feizi M; Mahdaviani P; Jamalifar H; Baeeri M; Dehghan G; Abdollahi M
J Physiol Pharmacol; 2011 Jun; 62(3):341-6. PubMed ID: 21893695
[TBL] [Abstract][Full Text] [Related]
26. Probiotic mixture supplementation in the preventive management of trinitrobenzenesulfonic acid-induced inflammation in a murine model.
Traina G; Menchetti L; Rappa F; Casagrande-Proietti P; Barbato O; Leonardi L; Carini F; Piro F; Brecchia G
J Biol Regul Homeost Agents; 2016; 30(3):895-901. PubMed ID: 27655518
[TBL] [Abstract][Full Text] [Related]
27. Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment.
Zakostelska Z; Kverka M; Klimesova K; Rossmann P; Mrazek J; Kopecny J; Hornova M; Srutkova D; Hudcovic T; Ridl J; Tlaskalova-Hogenova H
PLoS One; 2011; 6(11):e27961. PubMed ID: 22132181
[TBL] [Abstract][Full Text] [Related]
28. Lactobacillus casei LH23 modulates the immune response and ameliorates DSS-induced colitis via suppressing JNK/p-38 signal pathways and enhancing histone H3K9 acetylation.
Liu M; Ding J; Zhang H; Shen J; Hao Y; Zhang X; Qi W; Luo X; Zhang T; Wang N
Food Funct; 2020 Jun; 11(6):5473-5485. PubMed ID: 32495801
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide.
Macho Fernandez E; Valenti V; Rockel C; Hermann C; Pot B; Boneca IG; Grangette C
Gut; 2011 Aug; 60(8):1050-9. PubMed ID: 21471573
[TBL] [Abstract][Full Text] [Related]
30. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model.
Daniel C; Poiret S; Goudercourt D; Dennin V; Leyer G; Pot B
Appl Environ Microbiol; 2006 Sep; 72(9):5799-805. PubMed ID: 16957197
[TBL] [Abstract][Full Text] [Related]
31. The anti-inflammatory effects of a high-frequency oligodeoxynucleotide from the genomic DNA of Lactobacillus casei.
Hiramatsu Y; Satho T; Hyakutake M; Irie K; Mishima K; Miake F; Kashige N
Int Immunopharmacol; 2014 Nov; 23(1):139-47. PubMed ID: 25193776
[TBL] [Abstract][Full Text] [Related]
32. Lactobacillus casei and bifidobacterium lactis supplementation reduces tissue damage of intestinal mucosa and liver after 2,4,6-trinitrobenzenesulfonic acid treatment in mice.
Bellavia M; Rappa F; Lo Bello M; Brecchia G; Tomasello G; Leone A; Spatola G; Uzzo ML; Bonaventura G; David S; Damiani P; Hajj Hussein I; Zeenny MN; Jurjus A; Schembri-Wismayer P; Cocchi M; Zummo G; Farina F; Gerbino A; Cappello F; Traina G
J Biol Regul Homeost Agents; 2014; 28(2):251-61. PubMed ID: 25001657
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of P-glycoprotein by probiotics in intestinal epithelial cells and in the dextran sulfate sodium model of colitis in mice.
Saksena S; Goyal S; Raheja G; Singh V; Akhtar M; Nazir TM; Alrefai WA; Gill RK; Dudeja PK
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1115-23. PubMed ID: 21350189
[TBL] [Abstract][Full Text] [Related]
34. Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis.
Angulo S; Llopis M; Antolín M; Gironella M; Sans M; Malagelada JR; Piqué JM; Guarner F; Panés J
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G1155-62. PubMed ID: 16901988
[TBL] [Abstract][Full Text] [Related]
35. Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice.
Mendes MCS; Paulino DS; Brambilla SR; Camargo JA; Persinoti GF; Carvalheira JBC
World J Gastroenterol; 2018 May; 24(18):1995-2008. PubMed ID: 29760543
[TBL] [Abstract][Full Text] [Related]
36. VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice.
Wang CS; Li WB; Wang HY; Ma YM; Zhao XH; Yang H; Qian JM; Li JN
World J Gastroenterol; 2018 Oct; 24(37):4254-4262. PubMed ID: 30310258
[TBL] [Abstract][Full Text] [Related]
37. Potential of Lactobacillus plantarum ZDY2013 and Bifidobacterium bifidum WBIN03 in relieving colitis by gut microbiota, immune, and anti-oxidative stress.
Wang Y; Guo Y; Chen H; Wei H; Wan C
Can J Microbiol; 2018 May; 64(5):327-337. PubMed ID: 29401402
[TBL] [Abstract][Full Text] [Related]
38. Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis.
Philippe D; Heupel E; Blum-Sperisen S; Riedel CU
Int J Food Microbiol; 2011 Sep; 149(1):45-9. PubMed ID: 21257218
[TBL] [Abstract][Full Text] [Related]
39. The Impact of Lactobacillus casei on the Composition of the Cecal Microbiota and Innate Immune System Is Strain Specific.
Aktas B; De Wolfe TJ; Safdar N; Darien BJ; Steele JL
PLoS One; 2016; 11(5):e0156374. PubMed ID: 27244133
[TBL] [Abstract][Full Text] [Related]
40. Intragastric administration of Lactobacillus casei BL23 induces regulatory FoxP3+RORγt+ T cells subset in mice.
Cortes-Perez NG; Lozano-Ojalvo D; Maiga MA; Hazebrouck S; Adel-Patient K
Benef Microbes; 2017 May; 8(3):433-438. PubMed ID: 28504580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
